Sign Up Today and Learn More About Ring Therapeutics Stock
Invest in or calculate the value of your shares in Ring Therapeutics or other pre-IPO companies through EquityZen's platform.
Ring Therapeutics Stock (RINT)
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
About Ring Therapeutics Stock
Founded
2017
Headquarters
Cambridge, MA, US
Industries
Software, Data and Analytics, Artificial Intelligence
Ring Therapeutics Press Mentions
Stay in the know about the latest news on Ring Therapeutics
Madeline Schanen’s Post
linkedin • Aug 04, 2024
In major step toward the clinic, Ring's human viral vector delivers gene therapy to eyes of mice
fiercebiotech • May 23, 2024
ASGCT: Ring's 'new class of viral vector' is re-dosable in primates, overcoming key challenge of AAVs
fiercebiotech • May 23, 2024
Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff
statnews • Apr 07, 2024
Ring Therapeutics Publishes a Novel Gene Delivery Platform Based on the Commensal Human Anellovirus
morningstar • Apr 01, 2024
Ring Therapeutics Management
Leadership team at Ring Therapeutics
Chief Technology Officer
Konstantin Konstantinov
Independent Director
David Epstein
Join now and verify your accreditation status to gain access to:
- Ring Therapeutics current valuation
- Ring Therapeutics stock price
- Available deals in Ring Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Ring Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Ring Therapeutics through EquityZen funds. These investments are made available by existing Ring Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Ring Therapeutics stock?
Shareholders can sell their Ring Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
